DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
Myeloperoxidase (MPO)
|
OTOOXLIN
|
PERM_HUMAN
|
Increases ADR
|
[21] |
Solute carrier family 22 member 1 (SLC22A1)
|
OT7817I4
|
S22A1_HUMAN
|
Decreases Activity
|
[22] |
Solute carrier family 22 member 6 (SLC22A6)
|
OTKRCBVM
|
S22A6_HUMAN
|
Decreases Activity
|
[22] |
Organic anion transporter 7 (SLC22A9)
|
OTO4BJCC
|
S22A9_HUMAN
|
Decreases Activity
|
[22] |
Solute carrier family 22 member 11 (SLC22A11)
|
OTAJLNJZ
|
S22AB_HUMAN
|
Decreases Activity
|
[22] |
Solute carrier family 22 member 7 (SLC22A7)
|
OTKTNH1W
|
S22A7_HUMAN
|
Decreases Activity
|
[22] |
Aromatase (CYP19A1)
|
OTZ6XF74
|
CP19A_HUMAN
|
Decreases Expression
|
[23] |
Prostaglandin G/H synthase 1 (PTGS1)
|
OTHCRLEC
|
PGH1_HUMAN
|
Decreases Activity
|
[24] |
Diamine acetyltransferase 1 (SAT1)
|
OT52AU22
|
SAT1_HUMAN
|
Increases Expression
|
[25] |
Suppressor of cytokine signaling 3 (SOCS3)
|
OTY183WJ
|
SOCS3_HUMAN
|
Affects Expression
|
[26] |
Ephrin type-B receptor 6 (EPHB6)
|
OTKNN6GC
|
EPHB6_HUMAN
|
Affects Expression
|
[26] |
Arachidonate 12-lipoxygenase, 12R-type (ALOX12B)
|
OTQ0BYK6
|
LX12B_HUMAN
|
Affects Expression
|
[26] |
Annexin A9 (ANXA9)
|
OTKNYMU2
|
ANXA9_HUMAN
|
Decreases Expression
|
[26] |
Metastasis-associated protein MTA2 (MTA2)
|
OTCCYIQJ
|
MTA2_HUMAN
|
Increases Expression
|
[26] |
Integrin beta-like protein 1 (ITGBL1)
|
OTJDHE17
|
ITGBL_HUMAN
|
Affects Expression
|
[26] |
Complement C3 (C3)
|
OTCH5GS0
|
CO3_HUMAN
|
Affects Expression
|
[26] |
Interleukin-1 alpha (IL1A)
|
OTPSGILV
|
IL1A_HUMAN
|
Increases Expression
|
[26] |
Annexin A1 (ANXA1)
|
OT5OFDJC
|
ANXA1_HUMAN
|
Affects Expression
|
[26] |
Superoxide dismutase , mitochondrial (SOD2)
|
OTIWXGZ9
|
SODM_HUMAN
|
Increases Expression
|
[26] |
Interleukin-6 (IL6)
|
OTUOSCCU
|
IL6_HUMAN
|
Increases Expression
|
[26] |
Peptide YY (PYY)
|
OTXX6AF5
|
PYY_HUMAN
|
Decreases Expression
|
[26] |
Clusterin (CLU)
|
OTQGG0JM
|
CLUS_HUMAN
|
Affects Expression
|
[26] |
Collagen alpha-1(XI) chain (COL11A1)
|
OTB0DRMS
|
COBA1_HUMAN
|
Affects Expression
|
[26] |
Annexin A3 (ANXA3)
|
OTDD8OI7
|
ANXA3_HUMAN
|
Affects Expression
|
[26] |
C-C motif chemokine 2 (CCL2)
|
OTAD2HEL
|
CCL2_HUMAN
|
Increases Expression
|
[26] |
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1)
|
OTPWI88U
|
CEAM1_HUMAN
|
Affects Expression
|
[26] |
Tissue factor (F3)
|
OT3MSU3B
|
TF_HUMAN
|
Increases Expression
|
[26] |
Phospholipase A2, membrane associated (PLA2G2A)
|
OT1NY7BF
|
PA2GA_HUMAN
|
Affects Expression
|
[26] |
Fatty acid-binding protein, adipocyte (FABP4)
|
OT3DKFOU
|
FABP4_HUMAN
|
Decreases Expression
|
[26] |
NAD(P)H dehydrogenase 1 (NQO1)
|
OTZGGIVK
|
NQO1_HUMAN
|
Affects Expression
|
[26] |
Myelin and lymphocyte protein (MAL)
|
OTBM30SW
|
MAL_HUMAN
|
Increases Expression
|
[26] |
Cadherin-3 (CDH3)
|
OTKNLQU7
|
CADH3_HUMAN
|
Affects Expression
|
[26] |
Tenascin (TNC)
|
OTK4FSHR
|
TENA_HUMAN
|
Increases Expression
|
[26] |
Nitric oxide synthase 1 (NOS1)
|
OT7M8XVG
|
NOS1_HUMAN
|
Affects Expression
|
[26] |
Protein PML (PML)
|
OT6SM2GD
|
PML_HUMAN
|
Affects Expression
|
[26] |
Tumor necrosis factor receptor superfamily member 3 (LTBR)
|
OT2HVZGV
|
TNR3_HUMAN
|
Decreases Expression
|
[26] |
Prostaglandin E2 receptor EP3 subtype (PTGER3)
|
OTQODQUN
|
PE2R3_HUMAN
|
Affects Expression
|
[26] |
Protein FosB (FOSB)
|
OTW6C05J
|
FOSB_HUMAN
|
Increases Expression
|
[26] |
Fractalkine (CX3CL1)
|
OTPLGI0E
|
X3CL1_HUMAN
|
Affects Expression
|
[26] |
Insulinoma-associated protein 1 (INSM1)
|
OTG8RV8E
|
INSM1_HUMAN
|
Decreases Expression
|
[26] |
Max dimerization protein 1 (MXD1)
|
OTS5CTHX
|
MAD1_HUMAN
|
Increases Expression
|
[26] |
Desmocollin-1 (DSC1)
|
OTNII6GZ
|
DSC1_HUMAN
|
Affects Expression
|
[26] |
Corneodesmosin (CDSN)
|
OTQW4HV6
|
CDSN_HUMAN
|
Affects Expression
|
[26] |
Microtubule-associated protein RP/EB family member 2 (MAPRE2)
|
OTAE3MX4
|
MARE2_HUMAN
|
Affects Expression
|
[26] |
Voltage-dependent calcium channel subunit alpha-2/delta-3 (CACNA2D3)
|
OTEH9HGE
|
CA2D3_HUMAN
|
Affects Expression
|
[26] |
Secreted frizzled-related protein 3 (FRZB)
|
OTTO3DPY
|
SFRP3_HUMAN
|
Affects Expression
|
[26] |
Hydroperoxide isomerase ALOXE3 (ALOXE3)
|
OT76J52A
|
LOXE3_HUMAN
|
Affects Expression
|
[26] |
T-lymphocyte surface antigen Ly-9 (LY9)
|
OT1PKGDI
|
LY9_HUMAN
|
Decreases Expression
|
[26] |
Transmembrane protease serine 4 (TMPRSS4)
|
OTCCGY2K
|
TMPS4_HUMAN
|
Affects Expression
|
[26] |
A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAMTS8)
|
OT2KFY1S
|
ATS8_HUMAN
|
Increases Expression
|
[26] |
Sulfotransferase 1E1 (SULT1E1)
|
OTGPJ517
|
ST1E1_HUMAN
|
Decreases Activity
|
[27] |
Aldo-keto reductase family 1 member C3 (AKR1C3)
|
OTU2SXBA
|
AK1C3_HUMAN
|
Decreases Activity
|
[28] |
Aldo-keto reductase family 1 member C2 (AKR1C2)
|
OTQ2XMO3
|
AK1C2_HUMAN
|
Decreases Activity
|
[28] |
Aldo-keto reductase family 1 member C1 (AKR1C1)
|
OTQKR4CM
|
AK1C1_HUMAN
|
Decreases Activity
|
[28] |
PDZ and LIM domain protein 1 (PDLIM1)
|
OT4EGCPG
|
PDLI1_HUMAN
|
Decreases Expression
|
[8] |
Excitatory amino acid transporter 5 (SLC1A7)
|
OTVN5C6W
|
EAA5_HUMAN
|
Increases Expression
|
[8] |
Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT2)
|
OT8L6EGI
|
BCAT2_HUMAN
|
Increases Expression
|
[8] |
Monocarboxylate transporter 7 (SLC16A6)
|
OT7BIIZX
|
MOT7_HUMAN
|
Increases Expression
|
[8] |
Insulin-induced gene 1 protein (INSIG1)
|
OTZF5X1D
|
INSI1_HUMAN
|
Increases Expression
|
[8] |
Cochlin (COCH)
|
OTBEHD89
|
COCH_HUMAN
|
Decreases Expression
|
[8] |
5'-AMP-activated protein kinase subunit beta-2 (PRKAB2)
|
OTLVN68B
|
AAKB2_HUMAN
|
Decreases Expression
|
[8] |
NUAK family SNF1-like kinase 1 (NUAK1)
|
OTLLHJJQ
|
NUAK1_HUMAN
|
Decreases Expression
|
[8] |
Protein phosphatase 1 regulatory subunit 15A (PPP1R15A)
|
OTYG179K
|
PR15A_HUMAN
|
Increases Expression
|
[8] |
Ribosomal L1 domain-containing protein 1 (RSL1D1)
|
OT3CL4R3
|
RL1D1_HUMAN
|
Increases Expression
|
[8] |
Solute carrier organic anion transporter family member 2B1 (SLCO2B1)
|
OTERJ4VQ
|
SO2B1_HUMAN
|
Decreases Expression
|
[8] |
Tumor necrosis factor alpha-induced protein 8 (TNFAIP8)
|
OT1G9297
|
TFIP8_HUMAN
|
Decreases Expression
|
[8] |
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (GCNT3)
|
OTQ9ALTR
|
GCNT3_HUMAN
|
Increases Expression
|
[8] |
G1/S-specific cyclin-E2 (CCNE2)
|
OTBBUKQQ
|
CCNE2_HUMAN
|
Increases Expression
|
[8] |
Protein AMBP (AMBP)
|
OTLU8GU8
|
AMBP_HUMAN
|
Decreases Expression
|
[8] |
Fructose-bisphosphate aldolase A (ALDOA)
|
OTWRFTIB
|
ALDOA_HUMAN
|
Increases Expression
|
[8] |
Glucocorticoid receptor (NR3C1)
|
OTCI2YDI
|
GCR_HUMAN
|
Decreases Expression
|
[8] |
Cellular tumor antigen p53 (TP53)
|
OTIE1VH3
|
P53_HUMAN
|
Affects Activity
|
[8] |
Cytochrome P450 1A2 (CYP1A2)
|
OTLLBX48
|
CP1A2_HUMAN
|
Decreases Expression
|
[8] |
Alpha-enolase (ENO1)
|
OTB1KWJS
|
ENOA_HUMAN
|
Increases Expression
|
[8] |
Bifunctional glutamate/proline--tRNA ligase (EPRS1)
|
OTXK0FLB
|
SYEP_HUMAN
|
Increases Expression
|
[8] |
Amino acid transporter heavy chain SLC3A2 (SLC3A2)
|
OTBR33M9
|
4F2_HUMAN
|
Increases Expression
|
[8] |
Asparagine synthetase (ASNS)
|
OT8R922G
|
ASNS_HUMAN
|
Increases Expression
|
[8] |
Retinoic acid receptor alpha (RARA)
|
OT192V9V
|
RARA_HUMAN
|
Decreases Expression
|
[8] |
Endoplasmic reticulum chaperone BiP (HSPA5)
|
OTFUIRAO
|
BIP_HUMAN
|
Decreases Expression
|
[8] |
Solute carrier family 2, facilitated glucose transporter member 1 (SLC2A1)
|
OTA675TJ
|
GTR1_HUMAN
|
Increases Expression
|
[8] |
Histone H1.2 (H1-2)
|
OT0AVI4M
|
H12_HUMAN
|
Decreases Expression
|
[8] |
Aspartate aminotransferase, cytoplasmic (GOT1)
|
OTZLM5UB
|
AATC_HUMAN
|
Increases Expression
|
[8] |
Cyclic AMP-dependent transcription factor ATF-4 (ATF4)
|
OTRFV19J
|
ATF4_HUMAN
|
Affects Activity
|
[8] |
Transcription factor E3 (TFE3)
|
OTM99ZWH
|
TFE3_HUMAN
|
Increases Expression
|
[8] |
Retinoic acid receptor RXR-alpha (RXRA)
|
OTP1TBDM
|
RXRA_HUMAN
|
Decreases Expression
|
[8] |
Iduronate 2-sulfatase (IDS)
|
OTZO94EO
|
IDS_HUMAN
|
Increases Expression
|
[8] |
Tumor necrosis factor receptor superfamily member 6 (FAS)
|
OTP9XG86
|
TNR6_HUMAN
|
Decreases Expression
|
[8] |
DnaJ homolog subfamily B member 2 (DNAJB2)
|
OTZHPV5M
|
DNJB2_HUMAN
|
Increases Expression
|
[8] |
Adenylate kinase 4, mitochondrial (AK4)
|
OTA0T02Q
|
KAD4_HUMAN
|
Decreases Expression
|
[8] |
ETS domain-containing protein Elk-4 (ELK4)
|
OTVSSEOE
|
ELK4_HUMAN
|
Increases Expression
|
[8] |
High affinity cationic amino acid transporter 1 (SLC7A1)
|
OTR2ZVA8
|
CTR1_HUMAN
|
Increases Expression
|
[8] |
14-3-3 protein sigma (SFN)
|
OTLJCZ1U
|
1433S_HUMAN
|
Increases Expression
|
[8] |
Long-chain-fatty-acid--CoA ligase 1 (ACSL1)
|
OTB06ESI
|
ACSL1_HUMAN
|
Increases Expression
|
[8] |
Peroxisome proliferator-activated receptor gamma (PPARG)
|
OTHMARHO
|
PPARG_HUMAN
|
Affects Activity
|
[8] |
Isoleucine--tRNA ligase, cytoplasmic (IARS1)
|
OT9WXH5N
|
SYIC_HUMAN
|
Increases Expression
|
[8] |
Neutral amino acid transporter A (SLC1A4)
|
OTVODHAE
|
SATT_HUMAN
|
Increases Expression
|
[8] |
Nicotinamide phosphoribosyltransferase (NAMPT)
|
OTVJR3GL
|
NAMPT_HUMAN
|
Increases Expression
|
[8] |
ATP-binding cassette sub-family G member 1 (ABCG1)
|
OT5BG6MK
|
ABCG1_HUMAN
|
Increases Expression
|
[8] |
Sodium- and chloride-dependent glycine transporter 1 (SLC6A9)
|
OTHRUON2
|
SC6A9_HUMAN
|
Increases Expression
|
[8] |
Dipeptidyl peptidase 1 (CTSC)
|
OT79WJZZ
|
CATC_HUMAN
|
Decreases Expression
|
[8] |
Ataxin-1 (ATXN1)
|
OTQF0HNR
|
ATX1_HUMAN
|
Increases Expression
|
[8] |
Serine/threonine-protein kinase SIK1 (SIK1)
|
OT6FCHME
|
SIK1_HUMAN
|
Increases Expression
|
[8] |
Cyclin-dependent kinase 6 (CDK6)
|
OTR95N0X
|
CDK6_HUMAN
|
Decreases Expression
|
[8] |
Large neutral amino acids transporter small subunit 1 (SLC7A5)
|
OT2WPVXD
|
LAT1_HUMAN
|
Increases Expression
|
[8] |
1,4-alpha-glucan-branching enzyme (GBE1)
|
OTK2N05B
|
GLGB_HUMAN
|
Increases Expression
|
[8] |
Adenylate cyclase type 1 (ADCY1)
|
OTSLLFZO
|
ADCY1_HUMAN
|
Decreases Expression
|
[8] |
Enhancer of filamentation 1 (NEDD9)
|
OTGCFN4M
|
CASL_HUMAN
|
Decreases Expression
|
[8] |
Nuclear factor erythroid 2-related factor 2 (NFE2L2)
|
OT0HENJ5
|
NF2L2_HUMAN
|
Increases Expression
|
[8] |
kinase isozyme 4, mitochondrial (PDK4)
|
OTCMHMBZ
|
PDK4_HUMAN
|
Increases Expression
|
[8] |
Dual specificity protein phosphatase 5 (DUSP5)
|
OTH96RA7
|
DUS5_HUMAN
|
Increases Expression
|
[8] |
Laminin subunit alpha-3 (LAMA3)
|
OTFME7HT
|
LAMA3_HUMAN
|
Decreases Expression
|
[8] |
Tumor protein D53 (TPD52L1)
|
OTSA6U0I
|
TPD53_HUMAN
|
Increases Expression
|
[8] |
Glycerol-3-phosphate acyltransferase 3 (GPAT3)
|
OTJUGPK0
|
GPAT3_HUMAN
|
Increases Expression
|
[8] |
RRP12-like protein (RRP12)
|
OTQQAEH4
|
RRP12_HUMAN
|
Increases Expression
|
[8] |
Arginine/serine-rich coiled-coil protein 2 (RSRC2)
|
OTLE0KQM
|
RSRC2_HUMAN
|
Increases Expression
|
[8] |
Dipeptidyl peptidase 9 (DPP9)
|
OTBMZW2O
|
DPP9_HUMAN
|
Increases Expression
|
[8] |
Extracellular sulfatase Sulf-2 (SULF2)
|
OTIXMUVL
|
SULF2_HUMAN
|
Decreases Expression
|
[8] |
Probable ATP-dependent RNA helicase DHX37 (DHX37)
|
OTM1A5KP
|
DHX37_HUMAN
|
Increases Expression
|
[8] |
(Lyso)-N-acylphosphatidylethanolamine lipase (ABHD4)
|
OTQK3M9X
|
ABHD4_HUMAN
|
Increases Expression
|
[8] |
Pantothenate kinase 1 (PANK1)
|
OT2CZVRT
|
PANK1_HUMAN
|
Increases Expression
|
[8] |
SH3 domain and tetratricopeptide repeat-containing protein 1 (SH3TC1)
|
OT0HYZIU
|
S3TC1_HUMAN
|
Increases Expression
|
[8] |
Sortilin-related receptor (SORL1)
|
OTQ8FFNS
|
SORL_HUMAN
|
Decreases Expression
|
[8] |
Tumor protein p53-inducible nuclear protein 1 (TP53INP1)
|
OT2363Z9
|
T53I1_HUMAN
|
Decreases Expression
|
[8] |
Carboxymethylenebutenolidase homolog (CMBL)
|
OT8H3S3G
|
CMBL_HUMAN
|
Decreases Expression
|
[8] |
Protein FAM89A (FAM89A)
|
OTNASAXT
|
FA89A_HUMAN
|
Increases Expression
|
[8] |
Protein FAM210B, mitochondrial (FAM210B)
|
OT2QHEQ6
|
F210B_HUMAN
|
Decreases Expression
|
[8] |
Spermatid perinuclear RNA-binding protein (STRBP)
|
OTU7XLZL
|
STRBP_HUMAN
|
Increases Expression
|
[8] |
Perilipin-2 (PLIN2)
|
OTRXJ9UN
|
PLIN2_HUMAN
|
Increases Expression
|
[8] |
ETS-related transcription factor Elf-4 (ELF4)
|
OT167PR5
|
ELF4_HUMAN
|
Increases Expression
|
[8] |
Growth/differentiation factor 15 (GDF15)
|
OTWQN50N
|
GDF15_HUMAN
|
Increases Expression
|
[8] |
Ferroptosis suppressor protein 1 (AIFM2)
|
OT57XWXO
|
FSP1_HUMAN
|
Increases Expression
|
[8] |
Angiopoietin-related protein 4 (ANGPTL4)
|
OTQL5SPX
|
ANGL4_HUMAN
|
Increases Expression
|
[8] |
Sulfiredoxin-1 (SRXN1)
|
OTYDBO4L
|
SRXN1_HUMAN
|
Increases Expression
|
[8] |
Dual specificity protein phosphatase 22 (DUSP22)
|
OTEZ3U85
|
DUS22_HUMAN
|
Increases Expression
|
[8] |
Phospholipase A and acyltransferase 2 (PLAAT2)
|
OTI5RMWB
|
PLAT2_HUMAN
|
Increases Expression
|
[8] |
Leucine--tRNA ligase, cytoplasmic (LARS1)
|
OT4557NF
|
SYLC_HUMAN
|
Increases Expression
|
[8] |
Mitochondrial fission process protein 1 (MTFP1)
|
OT3L6F7U
|
MTFP1_HUMAN
|
Increases Expression
|
[8] |
Cystine/glutamate transporter (SLC7A11)
|
OTKJ6PXW
|
XCT_HUMAN
|
Increases Expression
|
[8] |
Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (ARFGEF2)
|
OTM3CQZT
|
BIG2_HUMAN
|
Increases Expression
|
[8] |
Protein piccolo (PCLO)
|
OTXJZZ98
|
PCLO_HUMAN
|
Increases Expression
|
[8] |
Prostaglandin reductase 1 (PTGR1)
|
OTMAR351
|
PTGR1_HUMAN
|
Affects Activity
|
[29] |
Inhibitor of nuclear factor kappa-B kinase subunit alpha (CHUK)
|
OTLF4ZB1
|
IKKA_HUMAN
|
Decreases Activity
|
[30] |
Tumor necrosis factor receptor superfamily member 21 (TNFRSF21)
|
OT3EDGXO
|
TNR21_HUMAN
|
Decreases Expression
|
[31] |
Tumor necrosis factor (TNF)
|
OT4IE164
|
TNFA_HUMAN
|
Increases Expression
|
[32] |
Interstitial collagenase (MMP1)
|
OTI4I2V1
|
MMP1_HUMAN
|
Increases Expression
|
[33] |
Amyloid-beta precursor protein (APP)
|
OTKFD7R4
|
A4_HUMAN
|
Decreases Expression
|
[34] |
Intercellular adhesion molecule 1 (ICAM1)
|
OTTOIX77
|
ICAM1_HUMAN
|
Decreases Expression
|
[35] |
Eukaryotic translation initiation factor 4E (EIF4E)
|
OTDAWNLA
|
IF4E_HUMAN
|
Increases Phosphorylation
|
[36] |
L-lactate dehydrogenase B chain (LDHB)
|
OT9B1CT3
|
LDHB_HUMAN
|
Affects Expression
|
[37] |
Annexin A2 (ANXA2)
|
OTFNS0CC
|
ANXA2_HUMAN
|
Affects Expression
|
[37] |
Thrombospondin-1 (THBS1)
|
OT0ECWK3
|
TSP1_HUMAN
|
Increases Expression
|
[38] |
Tumor necrosis factor receptor superfamily member 16 (NGFR)
|
OTPKSM49
|
TNR16_HUMAN
|
Increases Expression
|
[39] |
Stromelysin-1 (MMP3)
|
OTGBI74Z
|
MMP3_HUMAN
|
Increases Expression
|
[33] |
Galectin-1 (LGALS1)
|
OT8LDFWR
|
LEG1_HUMAN
|
Affects Expression
|
[37] |
Heat shock 70 kDa protein 1A (HSPA1A)
|
OTKGIE76
|
HS71A_HUMAN
|
Increases Expression
|
[40] |
Heat shock cognate 71 kDa protein (HSPA8)
|
OTJI2RCI
|
HSP7C_HUMAN
|
Affects Localization
|
[41] |
15-hydroxyprostaglandin dehydrogenase (HPGD)
|
OTYZI6JB
|
PGDH_HUMAN
|
Increases Expression
|
[42] |
Platelet glycoprotein 4 (CD36)
|
OT5CZWKY
|
CD36_HUMAN
|
Increases Expression
|
[43] |
Interleukin-1 receptor antagonist protein (IL1RN)
|
OT308CBE
|
IL1RA_HUMAN
|
Decreases Secretion
|
[44] |
Phosphoglycerate mutase 1 (PGAM1)
|
OTZ5DB06
|
PGAM1_HUMAN
|
Increases Expression
|
[37] |
Peroxiredoxin-6 (PRDX6)
|
OTS8KC8A
|
PRDX6_HUMAN
|
Affects Expression
|
[37] |
Peroxiredoxin-2 (PRDX2)
|
OTLWCY9T
|
PRDX2_HUMAN
|
Increases Expression
|
[37] |
Solute carrier family 15 member 1 (SLC15A1)
|
OT1P16B5
|
S15A1_HUMAN
|
Affects Binding
|
[45] |
Glutamate--cysteine ligase catalytic subunit (GCLC)
|
OTESDI4D
|
GSH1_HUMAN
|
Increases Expression
|
[46] |
Glutamate--cysteine ligase regulatory subunit (GCLM)
|
OT6CP234
|
GSH0_HUMAN
|
Increases Expression
|
[46] |
Fatty acid synthase (FASN)
|
OTFII9KG
|
FAS_HUMAN
|
Decreases Expression
|
[37] |
Beta-secretase 1 (BACE1)
|
OTCA7B6A
|
BACE1_HUMAN
|
Decreases Expression
|
[47] |
Triosephosphate isomerase (TPI1)
|
OT14KP4B
|
TPIS_HUMAN
|
Increases Expression
|
[37] |
GTP-binding nuclear protein Ran (RAN)
|
OT2TER5M
|
RAN_HUMAN
|
Affects Expression
|
[37] |
Peptidyl-prolyl cis-trans isomerase A (PPIA)
|
OTHJMWQQ
|
PPIA_HUMAN
|
Affects Expression
|
[37] |
Heat shock factor protein 1 (HSF1)
|
OTYNJ4KP
|
HSF1_HUMAN
|
Increases Activity
|
[48] |
POU domain, class 5, transcription factor 1 (POU5F1)
|
OTDHHN7O
|
PO5F1_HUMAN
|
Decreases Expression
|
[49] |
Cytochrome P450 4A11 (CYP4A11)
|
OTPU5J0S
|
CP4AB_HUMAN
|
Decreases Activity
|
[50] |
Plectin (PLEC)
|
OTU4XDEG
|
PLEC_HUMAN
|
Increases Expression
|
[37] |
Receptor tyrosine-protein kinase erbB-4 (ERBB4)
|
OT9L6C41
|
ERBB4_HUMAN
|
Affects Cleavage
|
[51] |
ELAV-like protein 1 (ELAVL1)
|
OTY55PLY
|
ELAV1_HUMAN
|
Increases Expression
|
[36] |
Hypoxia-inducible factor 1-alpha (HIF1A)
|
OTADSC03
|
HIF1A_HUMAN
|
Decreases Expression
|
[9] |
Sodium-coupled monocarboxylate transporter 1 (SLC5A8)
|
OTA0WELF
|
SC5A8_HUMAN
|
Decreases Activity
|
[52] |
Methylcytosine dioxygenase TET1 (TET1)
|
OTZDHT1D
|
TET1_HUMAN
|
Increases Expression
|
[49] |
ATP-dependent RNA helicase DDX1 (DDX1)
|
OT3U8FD0
|
DDX1_HUMAN
|
Affects Expression
|
[37] |
Endothelial PAS domain-containing protein 1 (EPAS1)
|
OTRE3O8U
|
EPAS1_HUMAN
|
Decreases Expression
|
[9] |
DNA (DNMT3A)
|
OTEJP0GH
|
DNM3A_HUMAN
|
Decreases Expression
|
[49] |
Prostaglandin G/H synthase 2 (PTGS2)
|
OT75U9M4
|
PGH2_HUMAN
|
Increases Response To Substance
|
[53] |
Arylamine N-acetyltransferase 2 (NAT2)
|
OTBPDQOY
|
ARY2_HUMAN
|
Increases ADR
|
[21] |
Lymphotoxin-alpha (LTA)
|
OTUC3S76
|
TNFB_HUMAN
|
Affects Response To Substance
|
[54] |
------------------------------------------------------------------------------------ |
|
|
|
|